Ananya Rajagopalan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ananya Rajagopalan has a total of 91 co-authors. Here are the top co-authors by number of shared publications:
- Ahyeon Hwang
Department of Computer Science, University of California Irvine, Irvine, California 92697, USA
1 shared publication Andre Luis Garao Rico
Department of Genetics, University of Pennsylvania
1 shared publicationAndrew C Yang
Program in Computational Biology and Bioinformatics, Yale University, New Haven, CT 06520, USA
1 shared publicationAnurag Verma
Department of Medicine, University of Pennsylvania
1 shared publicationAo Huang
Program in Computational Biology and Bioinformatics, Yale University, New Haven, CT 06520, USA
1 shared publication- Brie Wamsley
Program in Neurogenetics, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA
1 shared publication
Latest Publications
- Open Access
DRIVE-KG: Enhancing variant-phenotype association discovery in understudied complex diseases using heterogeneous knowledge graphs
Multi-omics data are instrumental in obtaining a comprehensive picture of complex biological systems. This is particularly useful for women’s health conditions, such as endometriosis which has been historically understudied despite having a high prevalence (around 10% of women of reproductive age). Subsequently, endometriosis has limited genetic characterization: current genome-wide association studies explain only 11% of its 47% total estimated heritability. Graph representations provide an intuitive and meaningful way to relate concepts across diverse data sources and address fundamental sparsity and dimensionality challenges with multi-omics data analysis. Here we present DRIVE-KG (Disease Risk Inference and Variant Exploration-Knowledge Graph), which uses a heterogeneous graph representation to integrate biological data from multi-omics datasets: dbSNP, NCBI Human Gene, Omics Pred, GTEx, and Open Targets. We drew directly from the knowledge captured in these data, using nodes to represent genes, single nucleotide polymorphisms, proteins, and phenotypes, and edges to represent relationships between these concepts. We trained two models using DRIVE-KG: a link prediction model to suggest associations between SNPs and two pilot phenotypes (endometriosis and obesity), and a graph convolutional network (GCN) to classify patient-level endometriosis status. We conducted the patient-level classification using data from 1,441 Penn Medicine BioBank participants with gold standard chart-reviewed endometriosis status. The link prediction model uncovered 66 high-confidence (score ≥ 0.95) previously unreported SNP-endometriosis associations. Many of these variants were linked to obesity/body mass index traits (24.2%), lipid metabolism (6%), and depressive disorders (4.5%), showing agreement with emerging hypotheses about endometriosis etiology. In contrast, 11% of the 149 high confidence, candidate SNP-obesity associations (score ≥ 0.9888) were in LD with known obesity associations. The GCN to classify patient endometriosis status had an AUPRC of 0.738 compared to 0.679 for a genetic risk score. Despite this moderate improvement, we found that the GCN learned meaningful stratification of underlying adenomyosis signal and severe grades of endometriosis. We have demonstrated that heterogeneous integration of multi-omics data is valuable for diverse downstream tasks—including discovery and clinical prediction—particularly for understudied diseases where traditional genomic approaches are insufficient.
Open AccessDRIVE-KG: Enhancing variant-phenotype association discovery in understudied complex diseases using heterogeneous knowledge graphs
Multi-omics data are instrumental in obtaining a comprehensive picture of complex biological systems. This is particularly useful for women’s health conditions, such as endometriosis which has been historically understudied despite having a high prevalence (around 10% of women of reproductive age). Subsequently, endometriosis has limited genetic characterization: current genome-wide association studies explain only 11% of its 47% total estimated heritability. Graph representations provide an intuitive and meaningful way to relate concepts across diverse data sources and address fundamental sparsity and dimensionality challenges with multi-omics data analysis. Here we present DRIVE-KG (Disease Risk Inference and Variant Exploration-Knowledge Graph), which uses a heterogeneous graph representation to integrate biological data from multi-omics datasets: dbSNP, NCBI Human Gene, Omics Pred, GTEx, and Open Targets. We drew directly from the knowledge captured in these data, using nodes to represent genes, single nucleotide polymorphisms, proteins, and phenotypes, and edges to represent relationships between these concepts. We trained two models using DRIVE-KG: a link prediction model to suggest associations between SNPs and two pilot phenotypes (endometriosis and obesity), and a graph convolutional network (GCN) to classify patient-level endometriosis status. We conducted the patient-level classification using data from 1,441 Penn Medicine BioBank participants with gold standard chart-reviewed endometriosis status. The link prediction model uncovered 66 high-confidence (score ≥ 0.95) previously unreported SNP-endometriosis associations. Many of these variants were linked to obesity/body mass index traits (24.2%), lipid metabolism (6%), and depressive disorders (4.5%), showing agreement with emerging hypotheses about endometriosis etiology. In contrast, 11% of the 149 high confidence, candidate SNP-obesity associations (score ≥ 0.9888) were in LD with known obesity associations. The GCN to classify patient endometriosis status had an AUPRC of 0.738 compared to 0.679 for a genetic risk score. Despite this moderate improvement, we found that the GCN learned meaningful stratification of underlying adenomyosis signal and severe grades of endometriosis. We have demonstrated that heterogeneous integration of multi-omics data is valuable for diverse downstream tasks—including discovery and clinical prediction—particularly for understudied diseases where traditional genomic approaches are insufficient.
- Top Cited Papers
- 24 May 2024
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 384 (6698) , eadi5199
Single-cell genomics and regulatory networks for 388 human brains
Single-cell genomics is a powerful tool for studying heterogeneous tissues such as the brain. Yet little is understood about how genetic variants influence cell-level gene expression. Addressing this, we uniformly processed single-nuclei, multiomics datasets into a resource comprising >2.8 million nuclei from the prefrontal cortex across 388 individuals. For 28 cell types, we assessed population-level variation in expression and chromatin across gene families and drug targets. We identified >550,000 cell type–specific regulatory elements and >1.4 million single-cell expression quantitative trait loci, which we used to build cell-type regulatory and cell-to-cell communication networks. These networks manifest cellular changes in aging and neuropsychiatric disorders. We further constructed an integrative model accurately imputing single-cell expression and simulating perturbations; the model prioritized ~250 disease-risk genes and drug targets with associated cell types.
- 24 May 2024
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 384 (6698) , eadi5199
Top Cited PapersSingle-cell genomics and regulatory networks for 388 human brains
Single-cell genomics is a powerful tool for studying heterogeneous tissues such as the brain. Yet little is understood about how genetic variants influence cell-level gene expression. Addressing this, we uniformly processed single-nuclei, multiomics datasets into a resource comprising >2.8 million nuclei from the prefrontal cortex across 388 individuals. For 28 cell types, we assessed population-level variation in expression and chromatin across gene families and drug targets. We identified >550,000 cell type–specific regulatory elements and >1.4 million single-cell expression quantitative trait loci, which we used to build cell-type regulatory and cell-to-cell communication networks. These networks manifest cellular changes in aging and neuropsychiatric disorders. We further constructed an integrative model accurately imputing single-cell expression and simulating perturbations; the model prioritized ~250 disease-risk genes and drug targets with associated cell types.